NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Forbes - NexMed's pipeline also includes a Phase 2 treatment for female sexual arousal disorder and an early stage treatment for psoriasis. For further information about the Company, go to www.nexmed.com. Statements under the Private Securities Litigation
Wednesday, November 21, 2007
NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Bookmark this post:
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment